Interval cancers as related to frequency of recall to assessment in the South Australian population-based breast screening program: An exploratory study.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
08 2022
Historique:
received: 27 09 2021
revised: 29 03 2022
accepted: 06 05 2022
pubmed: 25 5 2022
medline: 20 7 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Australian accreditation standards specify upper limits for percentages of women recalled for further assessment following screening mammography. These limits have been unchanged since national screening commenced circa 1990, although screening target ages have changed, and technology from analogue to digital mammography. This study compared 2804 women with interval cancers diagnosed since national screening began (cases) with 14,020 cancer-free controls (5 controls per case), randomly selected after matching by age, round, screen type and calendar year of screening episode, to determine the odds of interval cancer by differences in clinic recall to assessment percentages. Within low numbers of recalls that were within accepted accreditation ranges, results did not indicate more frequent recalls to assessment to be associated with fewer interval cancers in the analogue era. However, more frequent recalls were associated with reduced interval cancers for digital screens. These results are not conclusive, requiring confirmation in other screening environments, especially those with larger numbers of digital screens. If confirmed, frequency of recalls to assessment may need adjustment to get the best trade-offs in the digital era between reduced odds of interval cancers from more recalls and increases in financial and non-financial costs, including increased potential for overdiagnosis.

Identifiants

pubmed: 35609348
pii: S1877-7821(22)00088-1
doi: 10.1016/j.canep.2022.102183
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102183

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Terry Boyle (T)

Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia. Electronic address: Terry.boyle@unisa.edu.au.

Michelle Reintals (M)

BreastScreen South Australia, Adelaide, South Australia, Australia. Electronic address: Michelle.Reintals@sa.gov.au.

Andy Holmes (A)

BreastScreen South Australia, Adelaide, South Australia, Australia. Electronic address: Andrew.holmes@sa.gov.au.

Elizabeth Buckley (E)

Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia. Electronic address: Elizabeth.buckley@unisa.edu.au.

David Roder (D)

Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia. Electronic address: David.Roder@unisa.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH